Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
- 1 January 2007
- journal article
- Published by Springer Nature in BioDrugs
- Vol. 21 (1) , 1-7
- https://doi.org/10.2165/00063030-200721010-00001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Antiretroviral treatment of HIV infected adultsBMJ, 2006
- Anti-infective monoclonal antibodies: perils and promise of developmentNature Reviews Drug Discovery, 2006
- Viral and host factors in the pathogenesis of HIV infectionCurrent Opinion in Immunology, 2005
- Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped VirusesJournal of Virology, 2005
- Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding Kinetics and Binding Valence on Viral NeutralizationJournal of Molecular Biology, 2005
- The molecular basis of HIV capsid assembly—five years of progressReviews in Medical Virology, 2004
- Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune responseCellular Microbiology, 2003
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- A Direct Comparison of the Activities of Two Humanized Respiratory Syncytial Virus Monoclonal Antibodies: MEDI‐493 and RSHZl9The Journal of Infectious Diseases, 1999
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989